MRNA - Spark Newswire

1 minute read

Uncategorized

Doctor Offers A Chance To Win A Tesla After COVID-19 Vaccination

Today, 2:29 AM

While some people are scrambling to get the COVID-19 vaccine, some are hesitating for various reasons. But a family physician in Buffalo, New York, is doing his best to get as many people vaccinated as possible — even offering up a chance at winning a Tesla Inc (NASDAQ: TSLA) Model 3.

MRNA

1 minute read

Uncategorized

Yankees, Mets Baseball To Have Vaccinated, Unvaccinated Section

By Benzinga Newsdesk

Today, 2:29 AM

-Bloomberg

BNTX

1 minute read

Uncategorized

‘White House plans to redistribute unordered vaccine supply, telling states: Use it or lose it’ -Washington Post

By Benzinga Newsdesk

Today, 2:29 AM

https://www.washingtonpost.com/health/2021/05/04/vaccine-distribution-biden/

AZN

1 minute read

Uncategorized

Moderna Chairman Said Covid Virus May Become Endemic Like Seasonal Flu; Said Company is Ramping Up Production of Vaccine as Fast as it Can

By Charles Gross

Today, 2:29 AM

-Bloomberg

MRNA

2 minute read

Uncategorized

Pfizer COVID-19 Vaccine Expected To Get FDA Emergency Approval For Age Group 12-15 Next Week

By Shivdeep Dhaliwal

Today, 2:29 AM

The Food and Drug Administration has plans to authorize the emergency use of Pfizer Inc (NYSE: PFE) and BioNTech SE's (NASDAQ: BNTX) jointly-developed COVID-19 vaccine in adolescents aged between 12 to 15 years, t

BNTX

2 minute read

Uncategorized

Is Now The Time To Buy Stock In Vaxart Or Moderna?

By Henry Khederian

Today, 2:29 AM

One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why Is It Moving, or WIIM, feature in Benzinga Pro. WIIMs are a one-sentence description as to why that stock is moving. Here’s the latest news and updates for Vaxart and Moderna.

MRNA

1 minute read

Uncategorized

Moderna Inks Supply Pact Of 500M COVID-19 Vaccine Doses To COVAX Effort Starting Q4

By Vandana Singh

Today, 2:29 AM

Moderna Inc (NASDAQ: MRNA) has announced an agreement with vaccine promoter Gavi to supply up to 500 million doses of its COVID-19…

AZN

3 minute read

Uncategorized

Who Is — And Will Be — Making Money From COVID-19 Vaccines?

By Financialounge.com

Today, 2:29 AM

Schroders' Expert John Bowler Analyzes The Pharmaceutical Groups Involved In COVID-19 Drug Development, Emphasizing That Their Efforts Will Be Rewarded In The Future, Despite Current Low Benefits.

AZN